Question 1

What is CJC-1295/Ipamorelin?

Accepted Answer

CJC-1295/Ipamorelin is a combination of two growth hormone secretagogues that work through complementary pathways. CJC-1295 is a modified GHRH(1-29) analog that stimulates GH release through the GHRH receptor. Ipamorelin is a selective GHRP that stimulates GH release through the ghrelin/GHS-R1a receptor. Together they produce amplified GH pulsatility compared to either compound alone.

Question 2

Why are CJC-1295 and Ipamorelin combined in research?

Accepted Answer

The combination leverages two distinct GH release pathways simultaneously. CJC-1295 acts on the GHRH receptor to initiate GH pulse amplitude. Ipamorelin acts on GHS-R1a to amplify that pulse. Published research documents 3 to 5 times greater GH pulse amplitude with the combination versus either compound individually. This synergistic amplification is why the blend is the most studied GH secretagogue combination.

Question 3

What is the difference between CJC-1295 with DAC and without DAC?

Accepted Answer

DAC (Drug Affinity Complex) is a modification that extends the half-life of CJC-1295 from approximately 30 minutes to 6 to 8 days by binding to serum albumin. CJC-1295 without DAC (also called Modified GRF 1-29) produces more physiological pulsatile GH release patterns. Most combination research with Ipamorelin uses the no-DAC version because the pulsatile release pattern better mimics natural GH secretion.

Question 4

What is Ipamorelin selectivity?

Accepted Answer

Ipamorelin is considered the most selective GHRP because it stimulates GH release without significantly affecting cortisol, prolactin, or ACTH levels. Earlier GHRPs like GHRP-6 and GHRP-2 produced measurable cortisol and prolactin elevations. Anderson et al. documented this selectivity advantage in comparative pharmacology studies.

Question 5

What is the half-life of CJC-1295/Ipamorelin?

Accepted Answer

CJC-1295 (no DAC) has an approximate half-life of 30 minutes. Ipamorelin has an approximate half-life of 2 hours. The combination is typically administered in alignment with circadian GH secretion patterns, with published protocols examining pre-sleep timing to coincide with natural GH pulse windows.

Question 6

How is CJC-1295/Ipamorelin stored?

Accepted Answer

The lyophilized blend should be stored at -20 degrees Celsius for long-term stability. Once reconstituted, store at 2 to 8 degrees Celsius and use within the manufacturer specified timeframe. Both peptides in the blend are stable in the same reconstitution vehicle for research use.

Question 7

What purity should the blend meet?

Accepted Answer

Research-grade CJC-1295/Ipamorelin blends should document individual purity of each component at ≥98% by HPLC. Mass spectrometry should confirm the identity of both peptides. Spartan Peptides provides a 10mg blend with COA documentation. Source: /products/cjc-ipa-10-mg-blend/

Question 8

How does this combination compare to exogenous GH?

Accepted Answer

The CJC-1295/Ipamorelin combination stimulates endogenous GH release from the pituitary, preserving the natural pulsatile secretion pattern and feedback regulation. Exogenous GH provides a continuous supraphysiological level that can suppress endogenous production. Research comparing the two approaches notes the combination maintains IGF-1 elevation without the same degree of negative feedback suppression.

Question 9

Does circadian timing matter for CJC-1295/Ipamorelin research?

Accepted Answer

Yes. Published research documents that timing administration to coincide with natural GH pulse windows (particularly the sleep-onset GH surge) produces approximately 40% greater IGF-1 elevation compared to random timing. The circadian sensitivity of GH secretion is well established in endocrinology and applies directly to secretagogue research protocol design.

Question 10

What research areas involve CJC-1295/Ipamorelin?

Accepted Answer

Published research examines the combination across GH axis pharmacology, body composition studies in animal models, recovery and tissue repair paradigms, sleep architecture interactions, and age-related GH decline models. The most cited application is GH pulsatility research examining amplitude and frequency of secretion events.

GLP-3(Reta) | Triple-Agonist Metabolic Research

NAD+ 750mg | Cellular Energy & DNA Repair Research

MOTS-c | Mitochondrial Metabolism Research Peptide

BPC-157 5mg | Tissue Repair & Gut Health Research

CJC-1295/Ipamorelin Frequently Asked Questions

Explore Full Research Index